Pancreatic Cancer Canada CEO Michelle Capobianco speaks with Rick Zamperin, 900CHML, on the desperate need to raise the rate of pancreatic cancer survival Pancreatic Cancer Canada CEO Michelle Capobianco speaks with 900CHML host Rick Zamperin about the state of...
Pancreatic Cancer Canada and IMD Health Global announce partnership to improve the quality of patient education Toronto – July 21, 2022 Pancreatic Cancer Canada is pleased to announce an important new partnership with IMD Health. IMD Health is the largest digital...
PCC Welcomes New Leadership to Board of Directors Toronto – April 2022 Pancreatic Cancer Canada (PCC) is excited to announce the election of Jonathan Paul to the role of Chair and Chris Andrews to the role of Vice-Chair of our Board of Directors. Both Mr....
Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients....
New Clinical Trial Studies Pancreatic Cancer Tumor Traits to Uncover Better Treatment Options NEW YORK – March 30, 2021 – A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for...
Canadian Oncology Community Unites For World Cancer Day: Shedding Light on the Impact of Covid-19 on Cancer Care Oncologists estimate cancer diagnoses down 25 per cent in some areas as a result of COVID-19 Some oncologists are also reporting an increase in later...
Recent Comments